EUVIMEDObjevte EUVIMED
Open access

Constitutive AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity

Zhen Sun iD, Bernard Linares iD, Cassidy Urdiales, Fiyad Alsarmi, Boyuan Sang, Nagireddy Putluri iD, Jeanine L Van Nostrand iD

Science Advances · 2026-04-10 · 12 (15)

DOI: 10.1126/sciadv.aea8017 ↗

At a glance

Journal article in Science Advances, published on 2026-04-10. Written by Zhen Sun and 6 co-authors. Institution: Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA. Major MEDLINE topics: Hepatocyte Nuclear Factor 4, AMP-Activated Protein Kinases, Carcinoma, Hepatocellular, Liver Neoplasms. 132 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS, NIGMS NIH HHS, National Institutes of Health.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality and is largely driven by metabolic disorders such as obesity and type 2 diabetes. The AMP-activated protein kinase (AMPK) is a master regulator of metabolism, and its activation has been proposed as a therapeutic strategy for treating metabolic disorders. However, although AMPK activity is down-regulated in HCC, the precise role of AMPK in HCC development has not been clearly delineated. Here, we investigated the ability of constitutive AMPK activation to prevent HCC development using a constitutively active AMPK transgenic mouse model and a pharmacological AMPK activator. We observed that AMPK activation substantially reduced tumor formation in both diethylnitrosamine (DEN)–induced and streptozocin-induced (STAM) models of HCC via altered bile acid metabolism and inhibition of hepatic nuclear factor alpha (HNF4α) signaling. These findings provide mechanistic insights into AMPK biology and highlight the potential of AMPK as a therapeutic target, emphasizing the intricate interplay between metabolic dysregulation and cancer development.

Subjects

MeSH terms (MEDLINE)

Hepatocyte Nuclear Factor 4AMP-Activated Protein KinasesCarcinoma, HepatocellularLiver NeoplasmsAnimalsMiceEnzyme ActivationSignal TransductionMice, TransgenicBile Acids and SaltsDiethylnitrosamineHumans

Substances

Hepatocyte Nuclear Factor 4AMP-Activated Protein KinasesBile Acids and SaltsDiethylnitrosamineHnf4a protein, mouse

Authors and institutions

  • Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • Advanced Technology Core, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.

ORCID profiles: Zhen Sun, Bernard Linares, Nagireddy Putluri, Jeanine L Van Nostrand

Funding

  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Cancer Prevention and Research Institute of Texas
  • Dan L. Duncan Cancer Center, Baylor College of Medicine

Cite

APA

Sun, Z., Linares, B., Urdiales, C., Alsarmi, F., Sang, B., Putluri, N., & Van Nostrand, J. L. (2026). Constitutive AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity. Science Advances, 12(15). https://doi.org/10.1126/sciadv.aea8017

Vancouver

Sun Z, Linares B, Urdiales C, Alsarmi F, Sang B, Putluri N, et al. Constitutive AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity. Science Advances. 2026;12(15). doi:10.1126/sciadv.aea8017

BibTeX
@article{Sun2026,
  author = {Sun, Zhen and Linares, Bernard and Urdiales, Cassidy and Alsarmi, Fiyad and Sang, Boyuan and Putluri, Nagireddy and Van Nostrand, Jeanine L},
  title = {Constitutive AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {15},
  doi = {10.1126/sciadv.aea8017}
}
Start for free →